Avançar para navegação principal
Avançar para pesquisar
Avançar para conteúdo principal
Ordenar por
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
94%
Infection
53%
Infectious Disease
53%
Human Immunodeficiency Virus 2
38%
Neutralizing Antibody
25%
Genetic Variability
24%
Drug Resistance
20%
Cladistics
19%
Glycoprotein
17%
Virus
17%
Antibody Response
16%
Blood Plasma
13%
Viral Load
13%
Acquired Immune Deficiency Syndrome
13%
Prevalence
11%
Mycobacterium Tuberculosis
10%
Hepatitis C Virus
10%
Env (Gene)
9%
Plasmodium
9%
Epitope
8%
CXCR4
8%
Population Structure
7%
CD4
7%
Proteinase
6%
Protease
6%
Lineages
6%
Metagenomics
6%
Memory B Cell
6%
Genomic Surveillance
6%
Peptides
6%
Drug Sensitivity
6%
Immunoglobulin A
6%
Ribonucleic Acid
5%
Integrase
5%
Binding Antibody
5%
Vaccinia Virus
5%
Neutralization
5%
Medicine and Dentistry
Global Disease Burden
77%
Human Immunodeficiency Virus
49%
Diseases
22%
Prevalence
18%
Life Expectancy
16%
Mortality Rate
12%
Morbidity
12%
Mental Capacity
11%
HIV/AIDS
11%
Disability Adjusted Life Years
10%
Cluster Randomized Trial
10%
Respiratory Tract Infection
9%
Infection
9%
Human Immunodeficiency Virus 2
8%
Specific Mortality
8%
Systematic Review
8%
Health System
7%
Low and Middle Income Countries
7%
Non Communicable Disease
7%
Highly Active Antiretroviral Therapy
6%
Geographic Mapping
6%
Health Care Access
6%
Oral
6%
Diarrhea
6%
Tuberculosis
5%
fertility
5%
Age Groups
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
50%
Global Disease Burden
23%
Drug Resistance
18%
Diseases
16%
Prevalence
12%
Antimicrobial Agent
11%
Human Immunodeficiency Virus Fusion Inhibitor
10%
Anti-Human Immunodeficiency Virus
10%
Human Immunodeficiency Virus 1
10%
Peptide
10%
Lactam
6%
Human Immunodeficiency Virus 2
6%
Hepatitis C
6%
Drug Carrier
6%
Hepatitis B
6%
Polyethylene Glycol
6%
Nanoparticle
6%
Pharmacokinetics
6%
Simian Immunodeficiency Virus
6%
Hepatitis B Virus
6%
RNA Directed DNA Polymerase Inhibitor
5%
Nonnucleoside Reverse Transcriptase Inhibitor
5%
